팜스빌 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 신완균, was filed 30 Jan 2026.
팜스빌: what insiders have been doing
This page follows insider dealings at 팜스빌 as filed with DART (FSS), a company from the Health Care sector. 1 insider has disclosed 1 filing since 10 November 2025.
Every open-market trade in the period is a purchase: 1 purchase, from 1 insider, and not a single sale. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 1 board member among the declarants.
The latest purchase dates back some time: it was published 284 days ago, on 30 January 2026.
For context, the typical company on the same exchange (median of 2,648 companies) published 7 filings over the same period, against 1 filing here. Looking back to 2023, when coverage begins, insiders filed 2 purchases and 2 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,900 sharesShareKRXDART:20260130000121Canonical exit: 30 Apr 2026 (T+90)
- 862,896 sharesShareKRXDART:20250502000301Canonical exit: 31 Jul 2025 (T+90)
- 555,156 sharesKRXDART:20250502000338
- 800,000 sharesShareKRXDART:20250502000292
- ShareKRXDART:20230920000123
- ShareKRXDART:20230522000306
- ShareKRXDART:20230504000811
7 of 7 declarations
About 팜스빌
팜스빌 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and marketing of pharmaceutical products.